Status:
COMPLETED
Bone-biomarkers of Spinal Cord Injury Patients
Lead Sponsor:
Yeungnam University Hospital
Conditions:
Spinal Cord Injuries
Bone Resorption
Eligibility:
All Genders
20+ years
Brief Summary
Patients with spinal cord injury have a high prevalence of osteoporosis due to chronic skeletal unloading. Recently, various treatment drugs for osteoporosis have been developed. In particular, romoso...
Eligibility Criteria
Inclusion
- spinal cord injury patients
- Functional ambulatory category index of 3 or less
Exclusion
- history of using bone absorption medication within the effective period
Key Trial Info
Start Date :
February 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2021
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04403256
Start Date
February 5 2020
End Date
August 30 2021
Last Update
August 31 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yeungnam University Hospital
Daegu, South Korea, 42415